We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
-3.36%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$51.3B
AUM Growth
-$1.99B
(-3.7%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
31.61%
Holding
975
New
44
Increased
561
Reduced
289
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$734M |
| 2 |
Tesla
TSLA
|
+$576M |
| 3 |
Amazon
AMZN
|
+$501M |
| 4 |
Microsoft
MSFT
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$261M |
| 2 |
Equinix
EQIX
|
+$207M |
| 3 |
Ecolab
ECL
|
+$200M |
| 4 |
Coca-Cola
KO
|
+$194M |
| 5 |
Gilead Sciences
GILD
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.31% |
| 2 | Healthcare | 15.26% |
| 3 | Consumer Discretionary | 11.25% |
| 4 | Financials | 10.95% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Codexis
CDXS
$135M
| $1.63M | ﹤0.01% |
606,294
+97,671
| +19% | +$379K |
|
777
Syndax Pharmaceuticals
SNDX
$1.84B
| $1.63M | ﹤0.01% |
132,433
+33,093
| +33% | +$467K |
|
778
iShares MSCI Ireland ETF
EIRL
$74.9M
| $1.62M | ﹤0.01% |
27,463
| – | – |
|
779
Performance Food Group
PFGC
$17.5B
| $1.61M | ﹤0.01% |
20,461
+2,762
| +16% | +$231K |
|
780
Independence Realty Trust
IRT
$3.92B
| $1.61M | ﹤0.01% |
75,680
+3,133
| +4% | +$63.1K |
|
781
Solventum
SOLV
$13.5B
| $1.6M | ﹤0.01% |
21,416
-162,114
| -88% | -$12.1M |
|
782
Community Health Systems
CYH
$385M
| $1.6M | ﹤0.01% |
592,712
+504,377
| +571% | +$1.57M |
|
783
Takeda Pharmaceutical
TAK
$55.1B
| $1.56M | ﹤0.01% |
105,073
| – | – |
|
784
Huazhu Hotels Group
HTHT
$12.4B
| $1.56M | ﹤0.01% |
42,387
-71,643
| -63% | -$2.48M |
|
|
XRN
785
Chiron Real Estate Inc
XRN
$544M
| $1.53M | ﹤0.01% |
34,979
| – | – |
|
786
iShares MSCI India Small-Cap ETF
SMIN
$722M
| $1.48M | ﹤0.01% |
+21,700
| New | +$1.48M |
|
787
Korro Bio
KRRO
$153M
| $1.47M | ﹤0.01% |
+84,428
| New | +$2.5M |
|
|
JKS
788
JinkoSolar
JKS
$775M
| $1.46M | ﹤0.01% |
78,065
+30,340
| +64% | +$675K |
|
789
Ryman Hospitality Properties
RHP
$8.4B
| $1.43M | ﹤0.01% |
15,651
+548
| +4% | +$55K |
|
790
Tapestry
TPR
$28.8B
| $1.4M | ﹤0.01% |
20,261
-15,548
| -43% | -$1.18M |
|
791
Ralph Lauren
RL
$22.2B
| $1.39M | ﹤0.01% |
6,418
+24
| +0.4% | +$5.95K |
|
792
VTEX
VTEX
$665M
| $1.34M | ﹤0.01% |
+265,513
| New | +$1.51M |
|
|
CNTA
793
DELISTED
Centessa Pharmaceuticals
CNTA
| $1.31M | ﹤0.01% |
+90,883
| New | +$1.49M |
|
794
Tanger
SKT
$4.82B
| $1.27M | ﹤0.01% |
37,613
+2,121
| +6% | +$71.2K |
|
795
Itaú Unibanco
ITUB
$91.3B
| $1.27M | ﹤0.01% |
+237,616
| New | +$1.2M |
|
796
Allogene Therapeutics
ALLO
$601M
| $1.27M | ﹤0.01% |
867,250
+502,868
| +138% | +$948K |
|
797
Paylocity
PCTY
$6.71B
| $1.26M | ﹤0.01% |
6,730
| – | – |
|
798
EyePoint Inc
EYPT
$1.02B
| $1.25M | ﹤0.01% |
230,745
| – | – |
|
799
Perrigo
PRGO
$1.4B
| $1.24M | ﹤0.01% |
44,174
| – | – |
|
800
TScan Therapeutics
TCRX
$51.9M
| $1.23M | ﹤0.01% |
891,448
+7,744
| +0.9% | +$16.8K |
|
Similar funds
Aberdeen Group's Q1 2025 Portfolio in Review
As of Q1 2025, Aberdeen Group held 975 positions worth $51.3B, down 3.7% from $53.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Aberdeen Group deployed $1.6B of net new capital in Q1 2025, opening 44 new positions and adding to 561 existing holdings. Its largest new stake was REV Group: 816,327 shares worth $25.8M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $261M trimmed.
- Aberdeen Group's largest Q1 2025 buy was REV Group: 816,327 shares worth $25.8M.
- Aberdeen Group added most to Apple in Q1 2025, an estimated $734M increase.
- Aberdeen Group's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $261M.
- Aberdeen Group fully exited Altair Engineering Inc in Q1 2025, selling an estimated $61.9M.
- Aberdeen Group's ten largest holdings make up 32% of its $51.3B portfolio in Q1 2025.
- Aberdeen Group opened 44 new positions and closed 33 in Q1 2025.
- Aberdeen Group's portfolio value fell 3.7% quarter-over-quarter to $51.3B.
Based on Aberdeen Group's 13F filing for Q1 2025, filed 13 May 2025.